Single-center study utilizing C2 level as monitoring tool in de novo renal transplant recipients treated with neoral
- 1 November 2001
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 33 (7-8) , 3112-3114
- https://doi.org/10.1016/s0041-1345(01)02327-2
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- ABSORPTION PROFILING OF CYCLOSPORINE THERAPY FOR DE NOVO KIDNEY TRANSPLANTATION: A PROSPECTIVE, RANDOMIZED STUDY COMPARING SPARSE SAMPLING TO TROUGH MONITORING.Transplantation, 2000
- ABSORPTION PROFILING - A NOVEL METHOD FOR MONITORING NEORAL IN KIDNEY TRANSPLANTATION THAT REDUCES REJECTION AND NEPHROTOXICITY.Transplantation, 2000
- LOWER CYCLOSPORINE EXPOSURE INCREASES THE RISK FOR SUB-CLINICAL REJECTION IN RENAL TRANSPLANT RECIPIENTS.Transplantation, 2000
- NEORAL MONITORING BY SIMPLIFIED SPARSE SAMPLING AREA UNDER THE CONCENTRATION-TIME CURVETransplantation, 1999
- CHRONIC VIRAL HEPATITIS ENHANCES THE RISK OF INFECTION BUT NOT ACUTE REJECTION IN RENAL TRANSPLANT RECIPIENTS1Transplantation, 1996
- Immunosuppression induced by hepatitis C virus infection reduces acute renal-transplant rejectionThe Lancet, 1995